Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

Also called NCT01808287

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 250 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01808287
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada, France, Germany, Italy, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01808287. Non-randomized; no masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2013-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study
Acronym
SAPIEN3
Condition
Aortic Valve Disease
Intervention (Device)
Edwards SAPIEN 3 Transcatheter Heart Valve
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct01808287
Content hash
ff3a12157a42e6a4fefe4017c6099cd36193593c8ead210c9b298612727ced0a